AMH Equity’s Enzo Biochem, Inc. ENZ Stock Holding History

AMH Equity’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-30,000	Closed	-$87K	–	38
2022 Q1	$87K	Sell	30,000 -566,742	-95%	-$1.82M	0.09%	33
2021 Q4	$1.92M	Buy	+596,742	New	+$2.04M	2.66%	16

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AMH Equity's ENZ Position: Q2 2022 in Review

AMH Equity sold out of Enzo Biochem, Inc. (ENZ) in Q2 2022, closing a stake of 30,000 shares — an estimated $87K sold.

AMH Equity first reported a position in ENZ in Q4 2021 and held it in 2 quarters. The position peaked at $1.92M in Q4 2021. 54 funds tracked by Wall St. Rank hold ENZ as of Q2 2022.

AMH Equity reported no remaining Enzo Biochem, Inc. position as of Q2 2022 after selling out during the quarter.
AMH Equity sold 30,000 Enzo Biochem, Inc. shares in Q2 2022, an estimated $87K.
AMH Equity first reported a position in Enzo Biochem, Inc. in Q4 2021 and held it in 2 quarters.
AMH Equity's Enzo Biochem, Inc. position peaked at $1.92M in Q4 2021.
54 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2022.

Based on AMH Equity's 13F filing for Q2 2022, filed 1 Aug 2022.